117 related articles for article (PubMed ID: 21030693)
1. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
Peeters MC; van Westen GJ; Guo D; Wisse LE; Müller CE; Beukers MW; Ijzerman AP
FASEB J; 2011 Feb; 25(2):632-43. PubMed ID: 21030693
[TBL] [Abstract][Full Text] [Related]
2. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
[TBL] [Abstract][Full Text] [Related]
3. Domains for activation and inactivation in G protein-coupled receptors--a mutational analysis of constitutive activity of the adenosine A2B receptor.
Peeters MC; Li Q; Elands R; van Westen GJ; Lenselink EB; Müller CE; IJzerman AP
Biochem Pharmacol; 2014 Nov; 92(2):348-57. PubMed ID: 25179146
[TBL] [Abstract][Full Text] [Related]
4. Scanning mutagenesis in a yeast system delineates the role of the NPxxY(x)(5,6)F motif and helix 8 of the adenosine A(2B) receptor in G protein coupling.
Liu R; Nahon D; le Roy B; Lenselink EB; IJzerman AP
Biochem Pharmacol; 2015 Jun; 95(4):290-300. PubMed ID: 25896847
[TBL] [Abstract][Full Text] [Related]
5. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE
Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804
[TBL] [Abstract][Full Text] [Related]
6. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.
Beukers MW; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Brussee J; IJzerman AP
J Med Chem; 2004 Jul; 47(15):3707-9. PubMed ID: 15239649
[TBL] [Abstract][Full Text] [Related]
7. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cancer-related somatic mutations in the adenosine A
Wang X; Jespers W; Bongers BJ; Habben Jansen MCC; Stangenberger CM; Dilweg MA; Gutiérrez-de-Terán H; IJzerman AP; Heitman LH; van Westen GJP
Eur J Pharmacol; 2020 Aug; 880():173126. PubMed ID: 32348778
[TBL] [Abstract][Full Text] [Related]
9. The role of the second and third extracellular loops of the adenosine A1 receptor in activation and allosteric modulation.
Peeters MC; Wisse LE; Dinaj A; Vroling B; Vriend G; Ijzerman AP
Biochem Pharmacol; 2012 Jul; 84(1):76-87. PubMed ID: 22449615
[TBL] [Abstract][Full Text] [Related]
10. Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.
Gessi S; Varani K; Merighi S; Cattabriga E; Pancaldi C; Szabadkai Y; Rizzuto R; Klotz KN; Leung E; Mac Lennan S; Baraldi PG; Borea PA
Mol Pharmacol; 2005 Jun; 67(6):2137-47. PubMed ID: 15788741
[TBL] [Abstract][Full Text] [Related]
11. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
[TBL] [Abstract][Full Text] [Related]
14. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists.
Kim SK; Gao ZG; Van Rompaey P; Gross AS; Chen A; Van Calenbergh S; Jacobson KA
J Med Chem; 2003 Nov; 46(23):4847-59. PubMed ID: 14584936
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists.
Ivanov AA; Baskin II; Palyulin VA; Piccagli L; Baraldi PG; Zefirov NS
J Med Chem; 2005 Nov; 48(22):6813-20. PubMed ID: 16250640
[TBL] [Abstract][Full Text] [Related]
16. Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods.
Cheng F; Xu Z; Liu G; Tang Y
Eur J Med Chem; 2010 Aug; 45(8):3459-71. PubMed ID: 20537438
[TBL] [Abstract][Full Text] [Related]
17. Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.
Varani K; Caramori G; Vincenzi F; Tosi A; Barczyk A; Contoli M; Casolari P; Triggiani M; Hansel T; Leung E; Maclennan S; Barnes PJ; Chung KF; Adcock I; Papi A; Borea PA
FASEB J; 2010 Apr; 24(4):1192-204. PubMed ID: 20008542
[TBL] [Abstract][Full Text] [Related]
18. Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations.
Beukers MW; van Oppenraaij J; van der Hoorn PP; Blad CC; den Dulk H; Brouwer J; IJzerman AP
Mol Pharmacol; 2004 Mar; 65(3):702-10. PubMed ID: 14978249
[TBL] [Abstract][Full Text] [Related]
19. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.
Zhang JG; Hepburn L; Cruz G; Borman RA; Clark KL
Biochem Pharmacol; 2005 Mar; 69(6):883-9. PubMed ID: 15748700
[TBL] [Abstract][Full Text] [Related]
20. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.
Methner C; Schmidt K; Cohen MV; Downey JM; Krieg T
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1262-4. PubMed ID: 20709859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
